Johnson & Johnson (JNJ) closed the latest trading day at $166.09, indicating a +1.44% change from the previous session's end. This move outpaced the S&P 500's daily loss of 0.47%. Elsewhere, the Dow ...

Samsung Bioepis has allegedly sub-licensed its Stelara biosimilar rights to a health conglomerate, breaching a previous ...

"The demand environment remains consistent with our view of a gradual recovery in 2025," said CEO Satish Dhanasekaran.